You are here

Article Text

Article menu
Download PDFPDF
Prognosis
Cohort study
Women with cytologically atypical glandular cells are at increased risk of developing gynaecological malignancy
  1. Julie Ann Francis
  1. Department of Obstetrics & Gynaecology, Kingston General Hospital, Queen's University, Kingston, Ontario, Canada
  1. Correspondence to Julie Ann Francis
    Department of Obstetrics & Gynaecology, Kingston General Hospital, Queen's University, Victory 4, Kingston, ON K7L 2V7, Canada; julie.francis{at}queensu.ca

https://doi.org/10.1136/ebm1028

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Cheng WF, Chen YL, You SL, et al. Risk of gynaecological malignancies in cytologically atypical glandular cells: follow-up study of a nationwide screening population. BJOG 2011;118:34–41.OpenUrlCrossRefPubMedWeb of Science

    Context

    Cervical screening is a highly effective way to reduce the rate of cervical cancer, which is one of the leading causes of death in young women.1 The 2001 Bethesda System divides premalignant glandular lesions into atypical glandular cells (AGC), AGC favour neoplasia and adenocarcinoma in situ. Screening guidelines have typically assigned higher priority to these lesions because of their association with increased rates of gynaecologic malignancy.2 The Taiwanese annual cervical screening programme was launched in 1995, and investigators have analysed this database in order to better categorise the risks associated with AGC.

    Methods

    This is a large retrospective cohort trial of Taiwanese …

    View Full Text

    Footnotes

    • Competing interests None.